Am J Physiol Cell Physiol Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Cell Physiol (April 6, 2005). doi:10.1152/ajpcell.00111.2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
289/2/C352    most recent
00111.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pang, H.
Right arrow Articles by Gong, M. C
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pang, H.
Right arrow Articles by Gong, M. C
Submitted on March 10, 2005
Accepted on April 2, 2005

RhoA/Rho kinase mediates thrombin- and U-46619-induced phosphorylation of a myosin phosphatase inhibitor, CPI-17, in vascular smooth muscle cells

Huan Pang1, Zhenheng Guo1, Wen Su1, Zhongwen Xie1, Masumi Eto2, and Ming C Gong1*

1 Dept. of Physiology and Graduate Center for Nutritional Sciences, University of Kentucky, Lexington, KY, USA
2 Center for Cell Signaling, University of Virginia, Charlottesville, VA, USA

* To whom correspondence should be addressed. E-mail: mcgong2{at}uky.edu.

CPI-17 (Protein kinase C potentiated phosphatase inhibitor of 17 KD) mediates some agonist-induced smooth muscle contraction by suppressing the myosin phosphatase in a phosphorylation-dependent manner. Physiological relevant kinase(s) that phosphorylate CPI-17 remains to be identified. Several previous studies have shown that some agonist-induced CPI-17 phosphorylation in smooth muscle tissues was attenuated by the Rho kinase (ROCK) inhibitor Y-27632, suggesting ROCK is involved in agonist-induced CPI-17 phosphorylation. However, Y-27632 has recently been found to inhibit protein kinase C{delta}(PKC{delta}), a well- recognized CPI-17 kinase. Thus, the role of ROCK in agonist-induced CPI-17 phosphorylation remains uncertain. The current study is designed to address this important issue. We selectively activated the RhoA pathway by inducible adenoviral-mediated expression of a constitutively active mutant RhoA (V14RhoA) in primary cultured rabbit aortic smooth muscle cells (VSMCs). V14RhoA caused expression level-dependent CPI-17 phosphorylation at Thr-38 as well as myosin phosphatase phosphorylation at Thr-853. Importantly, we showed that V14RhoA-induced CPI-17 phosphorylation was not affected by PKC inhibitor GF109203x but was abolished by Y-27632, suggesting that ROCK but not PKC was involved. Further, we showed that contractile agonists, thrombin and U46619, induced CPI-17 phosphorylation in VSMCs. Similar to V14RhoA-induced CPI-17 phosphorylation, thrombin-induced CPI-17 phosphorylation was not affected by inhibition of PKC with GF109203x but was blocked by inhibition of RhoA with adenoviral-mediated expression of exoenzyme C3 as well as by Y-27632. Taken together, we provide the first clear evidence indicating that ROCK is responsible for thrombin- and U-46619-induced CPI-17 phosphorylation in primary cultured VSMCs.




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
P. H. Ratz and A. S. Miner
Role of Protein Kinase C{zeta} and Calcium Entry in KCl-Induced Vascular Smooth Muscle Calcium Sensitization and Feedback Control of Cellular Calcium Levels
J. Pharmacol. Exp. Ther., February 1, 2009; 328(2): 399 - 408.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Y. M. Seok, I. Baek, Y.-H. Kim, Y.-S. Jeong, I.-J. Lee, D. H. Shin, Y. H. Hwang, and I. K. Kim
Isoflavone Attenuates Vascular Contraction through Inhibition of the RhoA/Rho-Kinase Signaling Pathway
J. Pharmacol. Exp. Ther., September 1, 2008; 326(3): 991 - 998.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. W. Nuno, V. P. Korovkina, S. K. England, and K. G. Lamping
RhoA Activation Contributes to Sex Differences in Vascular Contractions
Arterioscler Thromb Vasc Biol, September 1, 2007; 27(9): 1934 - 1940.
[Abstract] [Full Text] [PDF]


Home page
GENES CELLSHome page
A. Maeda, Y.-i. Ozaki, S. Sivakumaran, T. Akiyama, H. Urakubo, A. Usami, M. Sato, K. Kaibuchi, and S. Kuroda
Ca-independent phospholipase A2-dependent sustained Rho-kinase activation exhibits all-or-none response.
Genes Cells, September 1, 2006; 11(9): 1071 - 1083.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
H. Pang, Z. Guo, Z. Xie, W. Su, and M. C. Gong
Divergent kinase signaling mediates agonist-induced phosphorylation of phosphatase inhibitory proteins PHI-1 and CPI-17 in vascular smooth muscle cells
Am J Physiol Cell Physiol, March 1, 2006; 290(3): C892 - C899.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
Z. Xie, W. Su, Z. Guo, H. Pang, S. R. Post, and M. C. Gong
Up-regulation of CPI-17 phosphorylation in diabetic vasculature and high glucose cultured vascular smooth muscle cells
Cardiovasc Res, February 1, 2006; 69(2): 491 - 501.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.